EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

S100 proteins in kidney disease: Inflammatory biomarkers, pathogenic mechanisms and therapeutic prospects (Review)

Hongfei Wang, Zhaoyang Li, Qianqian Li, Yufang Ni, Lifeng Meng, Jianchun Li

International Journal of Molecular Medicine · 30.10.2026 · 58 (6) · 1-15

DOI: 10.3892/ijmm.2026.6033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 30.10.2026. Verfasst von Hongfei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China. Hauptthemen laut MEDLINE: Biomarkers, Inflammation, S100 Proteins, Kidney Diseases. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The S100 protein family, particularly the calprotectin heterodimer S100A8/A9, is increasingly recognized as both an inflammatory readout and a context‑dependent mediator of kidney injury. Selected extracellular S100 proteins function as damage‑associated molecular patterns released during cellular stress, leukocyte activation and tissue injury. They can amplify sterile inflammation through the receptor for advanced glycation end‑products (RAGE), Toll‑like receptor 4 (TLR4) and related downstream pathways, although receptor usage and biological effects vary by cell type and disease setting. The present review examines S100 proteins in kidney disease across three related domains: Clinical biomarkers, disease mechanisms and therapeutic translation. Current evidence most strongly supports urinary S100A8/A9 for distinguishing intrinsic from pre‑renal acute kidney injury; circulating S100A8/A9 and S100A12 have mainly been studied as markers of inflammatory and cardiovascular risk in chronic kidney disease. S100‑associated signaling has been implicated in leukocyte recruitment, mesangial and macrophage activation, podocyte injury, tubular stress, tubulointerstitial fibrosis and uremia‑associated vascular calcification. Emerging studies also describe stress‑regulated and intracellular S100 functions, including gasdermin E (GSDME)‑regulated signal transducer and activator of transcription 3 (STAT3) signaling that controls S100A7A, S100‑annexin complexes and S100A16‑driven Wnt/β‑catenin or endoplasmic reticulum stress. However, therapeutic evidence remains largely preclinical, and clinical translation is constrained by ligand redundancy, disease heterogeneity and incomplete prospective validation. S100 proteins may therefore contribute to biomarker panels and targeted interventions, but their clinical utility requires prospective validation and clear separation of receptor‑mediated from intracellular effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersInflammationS100 ProteinsKidney DiseasesHumansAnimals

Stichwörter der Autor:innen

AKICKDDNRAGES100 proteinscalprotectinrenal fibrosisvascular calcification

Substanzen

BiomarkersS100 Proteins

Autor:innen und Institutionen

  • Department of Pathology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
  • Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
  • First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi Zhuang Autonomous Region 530000, P.R. China.

Zitieren

APA

Wang, H., Li, Z., Li, Q., Ni, Y., Meng, L., & Li, J. (2026). S100 proteins in kidney disease: Inflammatory biomarkers, pathogenic mechanisms and therapeutic prospects (Review). International Journal of Molecular Medicine, 58(6), 1-15. https://doi.org/10.3892/ijmm.2026.6033

Vancouver

Wang H, Li Z, Li Q, Ni Y, Meng L, Li J. S100 proteins in kidney disease: Inflammatory biomarkers, pathogenic mechanisms and therapeutic prospects (Review). International Journal of Molecular Medicine. 2026;58(6):1-15. doi:10.3892/ijmm.2026.6033

BibTeX
@article{Wang2026,
  author = {Wang, Hongfei and Li, Zhaoyang and Li, Qianqian and Ni, Yufang and Meng, Lifeng and Li, Jianchun},
  title = {S100 proteins in kidney disease: Inflammatory biomarkers, pathogenic mechanisms and therapeutic prospects (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2026},
  volume = {58},
  number = {6},
  pages = {1--15},
  doi = {10.3892/ijmm.2026.6033}
}
Kostenlos starten →